SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-2), cause of COVID-19
(Coronavirus Disease of 2019), represents a significant risk to people living with pre-existing …

Background/objectives Obesity decreases the secretion of SARS-CoV-2-specific IgG
antibodies in the blood of COVID-19 patients. How obesity impacts the quality of the …

Objective Obesity is associated with severe coronavirus disease 2019 (COVID‐19) infection.
Disease severity is associated with a higher COVID‐19 antibody titer. The COVID‐19 …

Obesity has emerged as a significant risk factor for severe COVID-19 worldwide. Given both
COVID-19 infection and obesity have been associated with increased systemic …

Background A greater understanding of the antibody response to SARS-CoV-2 in an
infected population is important for the development of a vaccination. Aim To investigate …

For the assessment of vaccine-induced immune response and to understand the role of
antibodies in neutralization, it is necessary to assess dynamics of various antibodies in …

Due to the adverse effects of obesity on host immunity, this study investigated the
effectiveness of COVID‐19 vaccines (BNT162b2, ChAdOx‐nCov‐2019, and mRNA‐1273) in …

In December 2019, a novel coronavirus known as SARS-CoV-2 was first detected in Wuhan,
China, causing outbreaks of the coronavirus disease COVID-19 that has now spread …

COVID‐19 vaccine is critical in preventing SARS‐CoV‐2 infection and transmission.
However, obesity's effect on immune responses to COVID‐19 vaccines is still unknown. We …

Abstract Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) has become a worldwide pandemic since it …